The results showed a significant elevation in activity of MMP-2 on 80 μM PSH treated NPC cells with exposure to U0126 or SP600125 when compared with PSH treatment only (Figures 4D–G). The gene discussed is MMP2; the disease is nasopharyngeal carcinoma.